Case Study: Champions Oncology accelerates cancer therapy development with Seqera

Champions Oncology cuts RNA-seq compute costs by 81% with Seqera

Champions Oncology, a global oncology research organization, faced challenges in scaling their multi-omics analysis for cancer therapy development. Their legacy infrastructure and limited automation slowed turnaround times, increased costs, and strained resources with the constant need to update and validate diverse pipelines. Managing complex sample types and data across multiple systems also hindered reproducibility and scalability.

By implementing Seqera's platform and Nextflow, they automated end-to-end processing and managed cloud compute efficiently. The solution delivered a 24x faster turnaround time, reducing analysis from days to hours. It also achieved an 81% reduction in compute costs for RNA-Seq and a 55% reduction for WES, allowing the team to focus on higher-impact research.

Champions Oncology